Categories
Research Insights
FDA: Natural History and Biomarker Studies of Rare Neurodegenerative Diseases
Invites proposals for efficient natural history studies and/or biomarker studies that fill unmet needs for rare neurodegenerative diseases for children and adults.
Amount: $2,416,000
Due Date: 5/4/23
